Bioventix Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Bioventix.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth39.7%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

Low

Last updated28 Oct 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:51B - Analysts future estimates and past financials data (GBP Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20251598111
6/30/202414888N/A
3/31/202414888N/A
12/31/202314988N/A
9/30/202313988N/A
6/30/202313888N/A
3/31/202313888N/A
12/31/202213888N/A
9/30/202212888N/A
6/30/202212888N/A
3/31/202211777N/A
12/31/202110777N/A
9/30/202111767N/A
6/30/202111766N/A
3/31/202111767N/A
12/31/202010777N/A
9/30/202010777N/A
6/30/202010778N/A
3/31/202010777N/A
12/31/201910767N/A
9/30/201910666N/A
6/30/20199666N/A
3/31/20199666N/A
12/31/20189666N/A
9/30/20189666N/A
6/30/20189666N/A
3/31/201896N/A5N/A
12/31/201786N/A5N/A
9/30/201785N/A4N/A
6/30/201775N/A4N/A
3/31/201775N/A4N/A
12/31/201664N/A4N/A
9/30/201664N/A3N/A
6/30/201663N/A3N/A
3/31/201653N/A3N/A
12/31/201553N/A2N/A
9/30/201553N/A2N/A
6/30/201543N/A2N/A
3/31/201542N/A2N/A
12/31/201442N/A2N/A
9/30/201442N/A2N/A
6/30/201442N/A2N/A
3/31/201432N/A2N/A
12/31/201332N/A2N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 51B's forecast earnings growth is above the savings rate (1%).

Earnings vs Market: Insufficient data to determine if 51B's earnings are forecast to grow faster than the German market

High Growth Earnings: Insufficient data to determine if 51B's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 51B's revenue is forecast to grow faster than the German market.

High Growth Revenue: Insufficient data to determine if 51B's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 51B's Return on Equity is forecast to be high in 3 years time


Discover growth companies